low cost glp 1 medication GLP-1 weight loss drugs to become cheaper for some under temporary Medicare program GLP-1 Supplement for Weight Management

Between 2021 and 2023, doctors wrote at least nine million prescriptions for Ozempic, its obesity-treating counterpart, Wegovy, and Mounjaro

Prevalence of obesity and severe obesity among adults: United states, 2017-2018

FDA-Approved : It is FDA-approved for type 2 diabetes, chronic weight management and obstructive sleep apnea (OSA), ensuring safety and efficacy for its intended use

Diabetologia (2010) 53(4):73040.10.1007/s00125-009-1643-x 55 KameokaJTanakaTNojimaYSchlossmanSFMorimotoC

[13] This trial was conducted in 20 countries: multiple European countries, Russia, Turkey, Brazil, Israel, Malaysia, Mexico, Thailand, Taiwan, Canada, and the United States